PATENT CLAIM ANALYSIS

Application Number: 16358935
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["424", "139100"]

Abstract:
The invention provides anti-human alpha-synuclein antibodies and methods of using the same.

Claim (Index 30):
A pharmaceutical formulation, comprising an antibody according to  claim 25  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15497782', '15847890', '14549102', '15284464', '15189711']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.821692358916258
- 35 USC 102 Novelty (BERT): 0.6537690954016413
- Combined Prediction Score: 0.8049000325647964
- Mean Citation Score: 674.3227860000002
- Max Citation Score: 744.0063
- Similarity Product: 579.8950003483416

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test